Rationale: A molecular test to distinguish between sepsis and systemic inflammation of
noninfectious etiology could potentially have clinical utility. Objectives: This study evaluated the …

Background There is an urgent need to develop biomarkers that stratify risk of bacterial
infection in order to support antimicrobial stewardship in emergency hospital admissions. …

Tools for the evaluation of COVID-19 severity would help clinicians with triage decisions,
especially the decision whether to admit to ICU. The aim of this study was to evaluate SeptiCyte …

Valley fever (VF) is difficult to diagnose, partly because the symptoms of VF are confounded
with those of other community-acquired pneumonias. Confirmatory diagnostics detect IgM …

Background Random-sequence peptide libraries are a commonly used tool to identify novel
ligands for binding antibodies, other proteins, and small molecules. It is often of interest to …

Diagnostics using peptide ligands have been available for decades. However, their adoption
in diagnostics has been limited, not because of poor sensitivity but in many cases due to …

SeptiCyte ® RAPID is a gene expression assay measuring the relative expression levels of
host response genes PLA2G7 and PLAC8, indicative of a dysregulated immune response …

Objectives: Sepsis, a life-threatening organ dysfunction caused by a dysregulated host
response to infection, is a leading cause of death and disability among children worldwide. …

We read with interest the article published online on 13 December 2023 by Peri et al.[1],
which evaluated the performance of a transcriptional host immune response signature (…

(1) Background: SeptiCyte RAPID is a molecular test for discriminating sepsis from non-infectious
systemic inflammation, and for estimating sepsis probabilities. The objective of this …